KR102334192B1 - Functional cosmetic composition comprising korean dandelion - Google Patents
Functional cosmetic composition comprising korean dandelion Download PDFInfo
- Publication number
- KR102334192B1 KR102334192B1 KR1020200186277A KR20200186277A KR102334192B1 KR 102334192 B1 KR102334192 B1 KR 102334192B1 KR 1020200186277 A KR1020200186277 A KR 1020200186277A KR 20200186277 A KR20200186277 A KR 20200186277A KR 102334192 B1 KR102334192 B1 KR 102334192B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- wild ginseng
- white dandelion
- water
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 76
- 239000002537 cosmetic Substances 0.000 title claims abstract description 53
- 241000245665 Taraxacum Species 0.000 title claims abstract description 20
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 title claims description 18
- 239000000284 extract Substances 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 241000208340 Araliaceae Species 0.000 claims abstract description 32
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 32
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 32
- 235000008434 ginseng Nutrition 0.000 claims abstract description 32
- 230000037303 wrinkles Effects 0.000 claims abstract description 32
- 230000006872 improvement Effects 0.000 claims abstract description 26
- 230000000694 effects Effects 0.000 claims abstract description 21
- 235000013376 functional food Nutrition 0.000 claims abstract description 13
- 230000036541 health Effects 0.000 claims abstract description 12
- 230000003796 beauty Effects 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 31
- 238000000605 extraction Methods 0.000 claims description 30
- 229940045761 evening primrose extract Drugs 0.000 claims description 21
- 235000008524 evening primrose extract Nutrition 0.000 claims description 21
- 229940067866 dandelion extract Drugs 0.000 claims description 20
- 235000020691 dandelion extract Nutrition 0.000 claims description 20
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims description 20
- 238000009472 formulation Methods 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 15
- 238000010992 reflux Methods 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 8
- 239000006210 lotion Substances 0.000 claims description 8
- 239000000839 emulsion Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 239000000375 suspending agent Substances 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 4
- 241001272081 Taraxacum coreanum Species 0.000 claims description 4
- 229960005305 adenosine Drugs 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006188 syrup Substances 0.000 claims description 4
- 235000020357 syrup Nutrition 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 239000000686 essence Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 239000002981 blocking agent Substances 0.000 claims description 2
- 239000004088 foaming agent Substances 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 229940014041 hyaluronate Drugs 0.000 claims description 2
- 210000002200 mouth mucosa Anatomy 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 239000010408 film Substances 0.000 claims 1
- 241000219925 Oenothera Species 0.000 abstract description 12
- 230000003078 antioxidant effect Effects 0.000 abstract description 12
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 12
- 239000004615 ingredient Substances 0.000 abstract description 9
- 230000002849 elastaseinhibitory effect Effects 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 6
- 229930014626 natural product Natural products 0.000 abstract description 5
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 description 26
- 238000012360 testing method Methods 0.000 description 18
- -1 ascorbic acid-2-phosphate sodium salt Chemical class 0.000 description 16
- 239000000523 sample Substances 0.000 description 13
- 239000003960 organic solvent Substances 0.000 description 12
- 235000004496 Oenothera biennis Nutrition 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- 238000000638 solvent extraction Methods 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 150000003722 vitamin derivatives Chemical class 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 6
- 238000003809 water extraction Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 102000016387 Pancreatic elastase Human genes 0.000 description 4
- 108010067372 Pancreatic elastase Proteins 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 4
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000006186 oral dosage form Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000864415 Cornus controversa Species 0.000 description 1
- 240000005109 Cryptomeria japonica Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 241001666358 Machilus japonica Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 240000008916 Oenothera biennis Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000005066 Rosa arkansana Nutrition 0.000 description 1
- 241000109365 Rosa arkansana Species 0.000 description 1
- 244000050053 Rosa multiflora Species 0.000 description 1
- 235000000656 Rosa multiflora Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000000185 intracerebroventricular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006201 parenteral dosage form Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical class [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 230000037330 wrinkle prevention Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 흰민들레를 유효성분으로 포함하는 기능성 화장료 조성물에 관한 것이다.The present invention relates to a functional cosmetic composition comprising white dandelion as an active ingredient.
최근 천연 소재와 친환경에 대한 관심이 높아짐에 따라 유기농 제품과 천연 제품에 대한 소비자의 선호도는 더 이상 음식과 음료에 국한하지 않고, 화장품 소재에서도 주목받고 있다. 인체 독성에 대한 우려를 막기위해 안전한 천연물질을 이용한 화장품 소재 개발이 활발하게 진행되고 있고, 이에 따라 국내외 천연 화장품 시장 또한 매년 성장하고 있다.Recently, as interest in natural materials and eco-friendliness increases, consumers' preference for organic products and natural products is no longer limited to food and beverages, but is also attracting attention from cosmetic materials. The development of cosmetic materials using safe natural materials is being actively conducted to prevent concerns about human toxicity, and accordingly, the domestic and overseas natural cosmetics market is also growing every year.
2018년 345억 달러 (한화 약 38조 7,000억 원) 규모였던 천연 화장품 시장은 연평균 5.2%가 증가해 2027년 전 세계 매출액이 545억 달러 (한화 약 61조 1,000억 원)에 이를 것으로 예상된다. 미래시장조사기관(Future Market Insights (FMI))에 따르면, 화장품과 세면용품에 화학 물질의 부작용에 대한 소비자의 우려가 증가하고 천연 성분의 이익에 관한 지식의 보급과 윤리적 소비주의의 증가에 힘입어 성장이 가속화되고 있는 것으로 나타났다.The natural cosmetics market, which was worth $34.5 billion (about 38.7 trillion won) in 2018, is expected to grow at an average annual rate of 5.2%, reaching $54.5 billion in global sales by 2027. According to Future Market Insights (FMI), growing consumer concerns about the side effects of chemicals in cosmetics and toiletries, and the dissemination of knowledge about the benefits of natural ingredients and the rise of ethical consumerism It appears that growth is accelerating.
흰민들레(Korean dandelion, Taraxacum coreanum)는 국화과(compositae)에 속한 다년초로 한방에서는 전초를 건조한 것을 봄과 여름에 꽃이 피기 전이나 후에 채취하여 청열해독, 소염, 이뇨의 목적으로 이용하는 포공영이라는 약물로 이용되어 왔다. 또한, 어린잎을 나물로 이용하고 뿌리는 약용으로 하였다는 기록이 있으며, 식품공전에는 민들레의 어린순, 어린잎, 뿌리부위를 식품의 주원료로 이용할 수 있는 것으로 수록하고 있다. 하지만, 이를 이용한 기능성 화장품으로의 활용은 아직까지 알려진 바가 없다.White dandelion (Korean dandelion, Taraxacum coreanum ) is a perennial plant belonging to the Compositae family. In oriental medicine, dried outflowers are collected before or after flowering in spring and summer and used for detoxification, anti-inflammatory and diuretic purposes. has been used In addition, there is a record that the young leaves were used as herbs and the roots were used for medicinal purposes. However, its use as a functional cosmetic using it is not known yet.
본 발명의 목적은 천연물을 이용한 주름개선의 기능성 조성물을 제공하는 데에 있다.An object of the present invention is to provide a functional composition for wrinkle improvement using a natural product.
상기의 목적을 달성하기 위하여, 본 발명은 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수를 포함하는 주름개선용 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a wrinkle improvement cosmetic composition comprising a white dandelion extract, an evening primrose extract and wild ginseng water.
본 발명은 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수를 포함하는 이너뷰티(inner beauty)용 조성물을 제공한다.The present invention provides a composition for inner beauty comprising a white dandelion extract, an evening primrose extract and wild ginseng water.
본 발명은 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수를 포함하는 주름개선용 약학 조성물을 제공한다.The present invention provides a wrinkle-improving pharmaceutical composition comprising a white dandelion extract, an evening primrose extract and wild ginseng water.
또한, 본 발명은 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수를 포함하는 주름개선용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for improving wrinkles comprising a white dandelion extract, an evening primrose extract and wild ginseng water.
본 발명에 따른 조성물은 우수한 항산화 활성 및 엘라스타제 억제 활성을 가진 강원도 특산 작물인 흰민들레, 달맞이꽃 등을 포함함으로써, 주름개선 기능을 위한 천연 성분의 화장료, 약학, 및 건강기능식품 조성물로 활용할 수 있다. The composition according to the present invention contains white dandelion, evening primrose, etc., which are special crops of Gangwon-do having excellent antioxidant activity and elastase inhibitory activity, so that it can be used as a cosmetic, pharmaceutical, and health functional food composition of natural ingredients for wrinkle improvement. have.
본 발명에 따른 조성물은 천연 성분을 활용함으로써, 기존에 사용되던 화학 물질의 독성 등 부작용을 줄여, 보다 안전하고 효과적으로 피부 주름개선에 사용될 수 있다.The composition according to the present invention can be used for improving skin wrinkles more safely and effectively by reducing side effects such as toxicity of previously used chemicals by utilizing natural ingredients.
도 1은 본 발명의 일 실시예에 따른 기능성 화장료 표준 원료 생산을 위한 강원도 특산 작물을 나타낸 것이다.
도 2 및 도 3은 본 발명의 일 실시예에 따른 원료 추출공정으로, 도 2는 흰민들레 및 달맞이꽃의 유기용매 추출공정, 도 3은 산양삼의 환류 추출공정을 도식화한 것이다.
도 4는 본 발명의 일 실시예에 따른 강원도 특산 작물 추출물을 이용한 화장료 표준 원료 생산의 전체 공정을 나타낸 것이다.
도 5는 상기 실시예에 따라 제조된 화장료 조성물의 세포 독성 실험 결과이다.
도 6 및 도 7은 상기 실시예에 따라 제조된 화장료 조성물의 주름개선 기능성을 확인한 실험으로, 도 6은 DPPH 라디컬 소거능 실험 결과, 도 7은 엘라스타제 억제활성 실험 결과이다.1 shows a special crop of Gangwon-do for the production of standard raw materials for functional cosmetics according to an embodiment of the present invention.
2 and 3 are a raw material extraction process according to an embodiment of the present invention, FIG. 2 is an organic solvent extraction process of white dandelion and evening primrose, and FIG. 3 is a schematic diagram of a reflux extraction process of wild ginseng.
Figure 4 shows the overall process of the cosmetic standard raw material production using the Gangwon-do specialty crop extract according to an embodiment of the present invention.
5 is a cytotoxicity test result of the cosmetic composition prepared according to the above example.
6 and 7 are an experiment confirming the wrinkle improvement function of the cosmetic composition prepared according to the above example, FIG. 6 is a DPPH radical scavenging activity test result, and FIG. 7 is an elastase inhibitory activity test result.
이하, 본 발명을 상세하게 설명하기로 한다.Hereinafter, the present invention will be described in detail.
본 발명은 강원도 특산작물인 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수를 포함하는 주름개선용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for wrinkle improvement comprising a white dandelion extract, an evening primrose extract and wild ginseng water, which are special crops of Gangwon-do.
바람직하게는, 상기 조성물은 흰민들레 추출물 5-15 중량%, 달맞이꽃 추출물 10-30 중량% 및 잔량의 산양삼수를 포함할 수 있다.Preferably, the composition may include 5-15% by weight of white dandelion extract, 10-30% by weight of evening primrose extract, and the remaining amount of wild ginseng water.
바람직하게는, 상기 조성물은 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수가 1:(1 내지 2):(1 내지 8) 중량비로 포함될 수 있고, 보다 바람직하게는 1:2:7 중량비로 포함될 수 있다.Preferably, the composition may include white dandelion extract, evening primrose extract and wild ginseng water in a weight ratio of 1: (1 to 2): (1 to 8), more preferably 1:2:7 by weight.
본 명세서에서, "추출물"이란, 추출 방법, 추출 용매, 추출된 성분 또는 추출물의 형태를 불문하고 천연물의 성분을 뽑아냄으로써 얻어진 물질을 의미하는 것으로, 천연물의 성분을 뽑아내어 얻어진 물질을 추출 후 다른 방법으로 가공 또는 처리하여 얻어질 수 있는 물질을 모두 포함할 수 있다.As used herein, the term "extract" refers to a substance obtained by extracting a component of a natural product regardless of an extraction method, an extraction solvent, an extracted component, or the form of an extract. It may include any material obtainable by processing or processing by the method.
상기 추출물은 당해 기술 분야에서 통상적으로 사용하는 방법에 따라 추출될 수 있고, 예를 들어, 열수 추출, 초음파 추출법, 여과법, 환류 추출법 등이 있으며, 이들은 단독으로 수행되거나 2종 이상의 방법을 병용하여 수행될 수 있다.The extract may be extracted according to a method commonly used in the art, for example, hot water extraction, ultrasonic extraction, filtration, reflux extraction, etc., which are performed alone or in combination of two or more methods. can be
바람직하게는, 상기 흰민들레 추출물은 흰민들레(Taraxacum coreanum Nakai)를 (C1~C4)알코올 수용액으로 추출한 추출물일 수 있고, 보다 바람직하게는, 상기 흰민들레의 꽃, 잎, 뿌리 부분 또는 이의 혼합 부분을 에탄올 수용액으로 추출한 것일 수 있으나, 이에 제한되는 것은 아니다.Preferably, the white dandelion extract may be an extract obtained by extracting white dandelion ( Taaxacum coreanum Nakai) with an aqueous (C1-C4) alcohol solution, and more preferably, the flower, leaf, root part, or a mixture thereof of the white dandelion. may be extracted with an aqueous ethanol solution, but is not limited thereto.
바람직하게는, 상기 달맞이꽃 추출물은 달맞이꽃(Oenothera biennis)을 (C1~C4)알코올 수용액으로 추출한 추출물일 수 있고, 보다 바람직하게는 달맞이꽃 건초를 에탄올 수용액으로 추출한 것일 수 있으나, 이에 제한되는 것은 아니다.Preferably, the evening primrose extract may be an extract obtained by extracting evening primrose ( Oenothera biennis ) with an aqueous (C1-C4) alcohol solution, and more preferably, evening primrose hay may be extracted with an aqueous ethanol solution, but is not limited thereto.
바람직하게는, 상기 산양삼수는 산양삼을 환류 추출하여 포집한 수증기 포집물일 수 있으나, 이제 제한되는 것은 아니다.Preferably, the wild ginseng water may be a water vapor collected by reflux extraction of wild ginseng, but is not limited thereto.
본 명세서에서, "주름개선"은 피부에 주름이 생성되는 것을 억제 또는 저해하거나, 이미 생성된 주름을 완화시키는 것을 의미한다. 주름 생성은 주로 콜라겐 또는 엘라스틴의 감소로 인해 발생하는 것이며, 상기 콜라겐 또는 엘라스틴의 감소는 과도한 산화 스트레스나 자외선 조사가 원인일 수 있다.As used herein, "wrinkle improvement" means suppressing or inhibiting the generation of wrinkles on the skin, or alleviating the already generated wrinkles. Wrinkle generation is mainly caused by a decrease in collagen or elastin, and the decrease in collagen or elastin may be caused by excessive oxidative stress or ultraviolet irradiation.
본 명세서에서, "화장료"란, 피부 노화, 주름 생성 등의 예방 또는 개선의 효과를 가지는 기능성 화장료를 포함할 수 있고, 상기 기능성 화장료는 일반 화장료와 달리 생리활성적인 효능, 효과가 강조된 전문적인 기능성을 갖는 것으로, 화장품법에 정의된 바에 따라 주름 개선 등 특정 효능과 효과가 강조된 화장료를 의미한다.As used herein, the term "cosmetics" may include functional cosmetics having an effect of preventing or improving skin aging, wrinkle generation, etc., and the functional cosmetics are professional functional cosmetics emphasizing physiologically active efficacy and effects, unlike general cosmetics. As defined by the Cosmetics Act, it means a cosmetic that emphasizes specific efficacy and effects such as wrinkle improvement.
상기 조성물은 우수한 항산화 활성 및 엘라스타제 억제 활성을 가지는 바, 주름개선용 화장료 조성물로 활용할 수 있다.Since the composition has excellent antioxidant activity and elastase inhibitory activity, it can be used as a cosmetic composition for improving wrinkles.
상기 주름개선은 피부 주름 예방, 개선, 피부 노화 억제 또는 개선 등 통상적인 피부 보호 효과를 포함할 수 있다. 또한, 콜라겐과 엘라스틴은 피부의 기계적 견고성, 조직의 결합력 및 탄력성 등에 관여하므로, 상기 조성물에 의해 피부 탄력 개선, 피부 재생, 상처 치유, 손상된 피부 조직의 수복 및 재생 등의 효과를 얻을 수 있다.The wrinkle improvement may include conventional skin protection effects such as skin wrinkle prevention, improvement, skin aging inhibition or improvement. In addition, since collagen and elastin are involved in the mechanical firmness of the skin, the bonding strength and elasticity of tissues, etc., effects such as skin elasticity improvement, skin regeneration, wound healing, and repair and regeneration of damaged skin tissue can be obtained by the composition.
상기 조성물은 아데노신, 하이알루로네이트, 및 글리세린으로 이루어진 군에서 선택된 하나 이상의 성분을 추가로 포함할 수 있으나, 이에 제한되지 않고, 식품의약품안전처에 등록된 화장품 원료 리스트 및 ICID(국제화장품 원료집)에 등재되어 있는 성분 중에서 1종 이상을 더 포함할 수 있다. The composition may further include one or more components selected from the group consisting of adenosine, hyaluronate, and glycerin, but is not limited thereto, and the cosmetic raw material list registered with the Ministry of Food and Drug Safety and ICID (International Cosmetic Ingredients Collection) ) may further include one or more of the listed ingredients.
예를 들어, 상기 화장료 조성물은 유기 용매, 용해제, 농축제, 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 방향제, 계면활성제, 유화제, 충전제, 금속이온 봉쇄제, 방부제, 비타민, 차단제, 습윤화제, 염료 및 안료, 친수성 또는 친유성 활성제, 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 하나 이상 더 포함할 수 있다.For example, the cosmetic composition may include an organic solvent, a solubilizer, a thickener, a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a fragrance, a surfactant, an emulsifier, a filler, a sequestering agent, a preservative, a vitamin, a blocking agent, It may further comprise one or more adjuvants commonly used in the cosmetic field, such as wetting agents, dyes and pigments, hydrophilic or lipophilic actives, or any other ingredients commonly used in cosmetics.
상기 비타민은 수용성 또는 유용성 비타민을 포함할 수 있고, 상기 수용성 비타민은 수용성 비타민으로서 화장품에 배합 가능한 것으로, 바람직하게는 비타민 B1, 비타민 B2, 비타민 B6, 피리독신, 염산피리독신, 비타민 B12, 판토텐산, 니코틴산, 니코틴산아미드, 엽산, 비타민C, 비타민 H 등을 들 수 있으며, 보다 바람직하게는 콜라겐 합성이 도움을 주는 비타민 C를 포함할 수 있다. 또한, 그들의 염 (티아민염산염, 아스코르빈산나트륨염 등)이나 유도체(아스코르빈산-2-인산나트륨염, 아스코르빈산-2-인산마그네슘염 등)도 포함될 수 있고, 상기 수용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 수득될 수 있다.The vitamin may include a water-soluble or oil-soluble vitamin, and the water-soluble vitamin is a water-soluble vitamin that can be formulated in cosmetics, preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine hydrochloride, vitamin B12, pantothenic acid, nicotinic acid, and nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like, and more preferably vitamin C, which helps collagen synthesis. In addition, salts thereof (thiamine hydrochloride, sodium ascorbate salt, etc.) or derivatives (ascorbic acid-2-phosphate sodium salt, ascorbic acid-2-phosphate magnesium salt, etc.) may be included, and the water-soluble vitamin is a microorganism transformation method , can be obtained by a conventional method such as a purification method from a culture of a microorganism, an enzymatic method or a chemical synthesis method.
본 발명에 따른 화장료 조성물은 본 발명이 속하는 기술 분야에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있다. 예를 들어, 화장수, 로션, 에센스, 크림, 페이스트, 젤, 용액, 현탁액, 유탁액, 오일, 왁스, 팩, 파우더, 파운데이션, 스프레이, 계면활성제-함유 클렌징 등으로 제형화 될 수 있으나, 이에 제한되는 것은 아니다. The cosmetic composition according to the present invention may be prepared in any formulation conventionally prepared in the technical field to which the present invention pertains. For example, it may be formulated as a lotion, lotion, essence, cream, paste, gel, solution, suspension, emulsion, oil, wax, pack, powder, foundation, spray, surfactant-containing cleansing, etc., but is limited thereto. it is not going to be
더욱 상세하게는, 유연 화장수, 영양 화장수, 수렴 화장수, 영양 크림, 마사지 크림, 밀크 로션, 파우더, 에센스, 아이 크림, 선로션, 선크림, 메이크업 프라이머, 메이크업 베이스, 비비크림, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 클렌징크림, 클렌징폼, 클렌징 워터, 비누, 팩, 스틱상 제품, 밤(Balm) 타입 제품, 스프레이 또는 파우더의 제형으로 제조될 수 있다.More specifically, flexible lotion, nourishing lotion, astringent lotion, nourishing cream, massage cream, milk lotion, powder, essence, eye cream, sun lotion, sun cream, makeup primer, makeup base, BB cream, powder foundation, emulsion foundation , wax foundation, cleansing cream, cleansing foam, cleansing water, soap, pack, stick product, balm type product, spray or powder formulation.
본 발명에 따른 화장료 조성물이 크림 또는 젤 제형인 경우에는 담체 성분으로 동물성유, 식물성유, 왁스, 파라핀, 전분, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등을 더 포함할 수 있다.When the cosmetic composition according to the present invention is a cream or gel formulation, animal oil, vegetable oil, wax, paraffin, starch, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be further included as a carrier component. can
상기 화장료 조성물이 용액 또는 유탁액 제형인 경우에는 용매, 용매화제 또는 유탁화제로, 물, 에탄올, 이소프로판올, 에틸카보네이트, 에틸아세테이트, 벤질알코올, 프로필렌글리콜, 글리세롤 지방족 에스테르, 폴리에틸렌글리콜 또는 소르비탄의 지방산 에스테르 등을 더 포함할 수 있다.When the cosmetic composition is a solution or emulsion formulation, a solvent, solvating agent or emulsifying agent, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, propylene glycol, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid It may further include esters and the like.
상기 화장료 조성물이 현탁액 제형인 경우에는 담체 성분으로 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등을 더 포함할 수 있다.When the cosmetic composition is a suspension formulation, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be further included.
상기 화장료 조성물이 파우더 또는 스프레이 제형인 경우에는 담체 성분으로 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더를 더 포함할 수 있고, 특히 스프레이 제형인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸에테르와 같은 추진체를 더 포함할 수 있다.When the cosmetic composition is in a powder or spray formulation, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be further included as a carrier component, and in particular, in the case of a spray formulation, additional chlorofluorohydrocarbon , may further include a propellant such as propane/butane or dimethyl ether.
상기 화장료 조성물이 계면활성제-함유 클렌징 제형인 경우에는 담체 성분으로 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등을 더 포함할 수 있다.When the cosmetic composition is a surfactant-containing cleansing formulation, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide as carrier components Ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glycerides, fatty acid diethanolamide, vegetable oil, linoline derivatives or ethoxylated glycerol fatty acid esters may be further included.
본 발명에 따른 화장료 조성물은 단독 또는 중복으로 도포하여 사용하거나, 본 발명 이외의 다른 화장료 조성물과 중복 도포하여 사용할 수 있다. 또한, 본 발명에 따른 화장료 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 그 사용횟수를 달리할 수 있다.The cosmetic composition according to the present invention may be used alone or by being applied in duplicate, or it may be used by applying it overlappingly with other cosmetic compositions other than the present invention. In addition, the cosmetic composition according to the present invention can be used according to a conventional method of use, and the number of times of use can be changed according to the skin condition or taste of the user.
본 발명은 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수를 포함하는 이너뷰티(inner beauty)용 조성물을 제공한다.The present invention provides a composition for inner beauty comprising a white dandelion extract, an evening primrose extract and wild ginseng water.
본 명세서에서, "이너뷰티(inner beauty)"란, 먹는 화장품을 의미하는 것으로, 화장품을 바르는 등 인위적인 방법으로 피부 표면만을 일시적으로 좋게 만드는 것이 아니라, 식품 등을 통해 피부 속, 내부에서부터 건강한 피부를 가꾸는 것을 의미한다.As used herein, "inner beauty" means eating cosmetics, and not only temporarily improving the skin surface by artificial methods such as applying cosmetics, but also providing healthy skin from the inside and the inside through food, etc. means caring for
바람직하게는, 상기 조성물은 흰민들레 추출물 5-15 중량%, 달맞이꽃 추출물 10-30 중량% 및 잔량의 산양삼수를 포함할 수 있다.Preferably, the composition may include 5-15% by weight of white dandelion extract, 10-30% by weight of evening primrose extract, and the remaining amount of wild ginseng water.
바람직하게는, 상기 조성물은 피부 주름 개선 효과를 가질 수 있다.Preferably, the composition may have a skin wrinkle improvement effect.
이에 상응하는 특징들은 상술된 부분에서 대신할 수 있다.Corresponding features may be substituted for the above-mentioned parts.
본 발명에 따른 이너뷰티용 조성물은 연화제, 항산화제, 현탁화제, 발포제, 계면활성제, 정제수, 이온형 또는 비이온형 유화제, 충전제, 보존제, 비타민, 차단제, 습윤화제, 염료, 안료, 친수성 또는 친유성 활성제 중에서 선택된 어느 하나 이상의 보조제를 추가로 포함할 수 있으나, 이에 제한되지 않고, 화장품학적으로 허용가능한 화장품 보조제, 약학적으로 허용가능한 약학 보조제, 식품학적으로 허용가능한 식품 보조제, 생물학적 활성 화합물, 흡수성 물질, 퍼스널 케어 화합물(personal care compound), 활성 성분, 미용 보조제 중 어느 하나 또는 이들의 조합을 더 포함할 수 있다.The composition for inner beauty according to the present invention is an emollient, antioxidant, suspending agent, foaming agent, surfactant, purified water, ionic or non-ionic emulsifier, filler, preservative, vitamin, blocker, wetting agent, dye, pigment, hydrophilic or hydrophilic It may further include any one or more adjuvants selected from oily active agents, but is not limited thereto, but is not limited thereto, but is not limited thereto, but is not limited thereto. It may further include any one of a substance, a personal care compound, an active ingredient, and a cosmetic adjuvant, or a combination thereof.
상기 조성물은 구강 점막용 필름, 정제, 시럽, 캡슐, 환제, 과립, 분말, 에어로졸 중에서 선택된 어느 하나 이상의 제형으로 이루어질 수 있으나, 이에 제한되는 것은 아니다.The composition may consist of any one or more formulations selected from films for oral mucosa, tablets, syrups, capsules, pills, granules, powders, and aerosols, but is not limited thereto.
본 발명은 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수를 포함하는 주름개선용 약학 조성물을 제공한다.The present invention provides a wrinkle-improving pharmaceutical composition comprising a white dandelion extract, an evening primrose extract and wild ginseng water.
상기 조성물은 우수한 항산화 활성 및 엘라스타제 억제 활성을 가짐으로써, 피부 주름개선을 위한 약학 조성물로 활용할 수 있다.Since the composition has excellent antioxidant activity and elastase inhibitory activity, it can be used as a pharmaceutical composition for skin wrinkle improvement.
이에 상응하는 특징들은 상술된 부분에서 대신할 수 있다.Corresponding features may be substituted for the above-mentioned parts.
본 발명에 따른 약학 조성물은 약학적 분야의 통상적인 방법에 따라 제조될 수 있다. 상기 약학 조성물은 제형에 따라 약학적으로 허용가능한 적절한 담체와 배합될 수 있고, 필요에 따라, 부형제, 희석제, 분산제, 유화제, 완충제, 안정제, 결합제, 붕해제, 용제 등을 더 포함하여 제조될 수 있다. 상기 적절한 담체 등은 본 발명에 따른 추출물의 활성 또는 특성을 저해하지 않는 것으로, 투여 형태 및 제형에 따라 달리 선택될 수 있다.The pharmaceutical composition according to the present invention may be prepared according to a conventional method in the pharmaceutical field. The pharmaceutical composition may be combined with a suitable pharmaceutically acceptable carrier according to the formulation, and if necessary, excipients, diluents, dispersants, emulsifiers, buffers, stabilizers, binders, disintegrants, solvents, etc. may be prepared further comprising have. The appropriate carrier and the like do not inhibit the activity or properties of the extract according to the present invention, and may be selected differently depending on the dosage form and formulation.
본 발명에 따른 약학 조성물은 어떠한 제형으로도 적용될 수 있고, 보다 상세하게는 통상의 방법에 따라 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 비경구형 제형으로 제형화하여 사용될 수 있다.The pharmaceutical composition according to the present invention can be applied in any dosage form, and more specifically, it can be used by formulating oral dosage forms, external preparations, suppositories, and parenteral dosage forms of sterile injection solutions according to conventional methods.
상기 경구형 제형 중 고형 제형은 정제, 환제, 산제, 과립제, 캡슐제 등의 형태로, 적어도 하나 이상의 부형제, 예를 들면, 전분, 칼슘카보네이트, 수크로스, 락토오스, 솔비톨, 만니톨, 셀룰로오스, 젤라틴 등을 섞어 조제할 수 있고, 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 포함될 수 있다. 또한, 캡술제형의 경우 상기 언급한 물질 외에도 지방유와 같은 액체 담체를 더 포함할 수 있다.The solid dosage form among the oral dosage forms is in the form of tablets, pills, powders, granules, capsules, etc., and at least one or more excipients, for example, starch, calcium carbonate, sucrose, lactose, sorbitol, mannitol, cellulose, gelatin, etc. In addition to simple excipients, lubricants such as magnesium stearate and talc may be included. In addition, the capsule formulation may further include a liquid carrier such as fatty oil in addition to the above-mentioned substances.
상기 경구형 제형 중 액상 제형은 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다.Among the oral dosage forms, liquid formulations include suspensions, solutions, emulsions, syrups, etc. In addition to water and liquid paraffin, which are commonly used simple diluents, various excipients, for example, wetting agents, sweeteners, fragrances, preservatives, etc. may be included. have.
상기 비경구 제형은 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함될 수 있다. 비수성용제, 현탁제로는 프로필렌글리콜, 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다. 이에 제한되지 않고, 당해 기술 분야에 알려진 적합한 제제를 모두 사용 가능하다.The parenteral formulation may include a sterile aqueous solution, a non-aqueous solution, a suspension, an emulsion, a freeze-dried formulation, and a suppository. Non-aqueous solvents and suspending agents include propylene glycol, polyethylene glycol, vegetable oils such as olive oil, and injectable esters such as ethyl oleate. As the base of the suppository, witepsol, macrogol, Tween 61, cacao butter, laurin fat, glycerogelatin, and the like can be used. It is not limited thereto, and any suitable agent known in the art may be used.
또한, 본 발명에 따른 약학 조성물은 치료 효능의 증진을 위해 칼슘이나 비타민 D3 등을 더 첨가할 수 있다.In addition, the pharmaceutical composition according to the present invention may further add calcium, vitamin D3, or the like to enhance therapeutic efficacy.
본 발명에 따른 약학 조성물은 약학적으로 유효한 양으로 투여될 수 있다. The pharmaceutical composition according to the present invention may be administered in a pharmaceutically effective amount.
본 명세서에서, "약학적으로 유효한 양"이란, 의학적 치료에 적용 가능한 합리적인 수혜/위험 비율로 질환을 치료하기에 충분하며 부작용을 일으키지 않을 정도의 양을 의미한다.As used herein, "pharmaceutically effective amount" means an amount sufficient to treat a disease at a reasonable benefit/risk ratio applicable to medical treatment and not to cause side effects.
상기 약학 조성물의 유효 용량 수준은 사용 목적, 환자의 연령, 성별, 체중 및 건강 상태, 질환의 종류, 중증도, 약물의 활성, 약물에 대한 민감도, 투여 방법, 투여 시간, 투여 경로 및 배출 비율, 치료기간, 배합 또는 동시 사용되는 약물을 포함한 요소 및 기타 의학 분야에 잘 알려진 요소에 따라 달리 결정될 수 있다. 예를 들어, 일정하지는 않지만 일반적으로 0.001 내지 100mg/kg으로, 바람직하게는 0.01 내지 10mg/kg을 일일 1회 내지 수회 투여될 수 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다.The effective dose level of the pharmaceutical composition may be determined according to the purpose of use, the age, sex, weight and health status of the patient, the type of disease, the severity, the activity of the drug, the sensitivity to the drug, the administration method, the administration time, the administration route and the excretion rate, the treatment The duration, formulation, or concomitant use may be determined differently depending on factors including drugs and other factors well known in the medical field. For example, although not constant, generally 0.001 to 100 mg/kg, preferably 0.01 to 10 mg/kg, may be administered once to several times a day. The above dosage does not limit the scope of the present invention in any way.
본 발명에 따른 약학 조성물은 제제 형태에 따른 적당한 투여 경로로 투여될 수 있고, 목적 조직에 도달할 수 있는 한 경구 또는 비경구의 다양한 경로를 통하여 투여될 수 있다. 투여 방법은 특히 한정할 필요 없이, 예를 들면, 경구, 직장 또는 정맥, 근육, 피부 도포, 피하, 호흡기내 흡입, 자궁내 경막 또는 뇌혈관내(intracere-broventricular) 주사 등의 통상적인 방법으로 투여될 수 있다.The pharmaceutical composition according to the present invention may be administered by an appropriate administration route according to the form of the formulation, and may be administered via various routes, either oral or parenteral, as long as it can reach the target tissue. The administration method does not need to be particularly limited, and for example, oral, rectal or intravenous, muscle, skin application, subcutaneous, respiratory inhalation, intrauterine dural or intracerebroventricular injection, etc. are administered in a conventional manner. can be
본 발명에 따른 약학 조성물은 피부 주름개선을 위하여 단독으로 사용될 수 있고, 수술 또는 다른 약물 치료 등과 병용하여 사용될 수 있다.The pharmaceutical composition according to the present invention may be used alone for skin wrinkle improvement, or may be used in combination with surgery or other drug treatment.
본 발명은 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수를 포함하는 주름개선용 건강기능식품 조성물을 제공한다.The present invention provides a wrinkle-improving health functional food composition comprising a white dandelion extract, an evening primrose extract and wild ginseng water.
상기 조성물은 우수한 항산화 활성 및 엘라스타제 억제 활성을 가짐으로써, 피부 주름개선을 위한 건강기능식품으로 활용될 수 있다.Since the composition has excellent antioxidant activity and elastase inhibitory activity, it can be used as a health functional food for skin wrinkle improvement.
이에 상응하는 특징들은 상술된 부분에서 대신할 수 있다.Corresponding features may be substituted for the above-mentioned parts.
본 발명에 따른 건강기능식품 조성물에 있어서, 상기 건강기능식품은 분말, 과립, 정제, 캡슐, 시럽 또는 음료 등으로 제조될 수 있고, 상기 건강기능식품이 취할 수 있는 형태에는 제한이 없으며, 통상적인 의미의 식품을 모두 포함할 수 있다. 예를 들어, 음료 및 각종 드링크, 과실 및 그의 가공식품(과일통조림, 잼 등), 어류, 육류 및 그 가공식품(햄, 베이컨 등), 빵류 및 면류, 쿠키 및 스낵류, 유제품(버터, 치즈 등) 등이 가능하며, 통상적인 의미에서의 기능성 식품을 모두 포함할 수 있다. 또한, 동물을 위한 사료로 이용되는 식품도 포함할 수 있다.In the health functional food composition according to the present invention, the health functional food may be prepared in powder, granule, tablet, capsule, syrup or beverage, etc., and there is no limitation in the form that the health functional food can take, It can include any food with meaning. For example, beverages and various drinks, fruits and their processed foods (canned fruit, jam, etc.), fish, meat and their processed foods (ham, bacon, etc.), breads and noodles, cookies and snacks, dairy products (butter, cheese, etc.) ), etc. are possible, and may include all functional foods in a conventional sense. It may also include food used as feed for animals.
본 발명에 따른 건강기능식품 조성물은 당업계에서 통상적으로 사용되는 식품학적으로 허용가능한 식품 첨가제 및 적절한 기타 보조 성분을 더 포함하여 제조될 수 있다. 예를 들어, 향미제, 천연 탄수화물, 감미제, 비타민, 전해질, 착색제, 펙트산, 알긴산, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산화제 등을 추가로 함유할 수 있다. The health functional food composition according to the present invention may be prepared by further including pharmaceutically acceptable food additives and other suitable auxiliary ingredients commonly used in the art. For example, flavoring agents, natural carbohydrates, sweeteners, vitamins, electrolytes, coloring agents, pectic acid, alginic acid, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents, etc. can
특히, 상기 천연 탄수화물로는 포도당, 과당과 같은 모노사카라이드, 말토스, 수크로오스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜을 사용할 수 있으며, 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다.In particular, as the natural carbohydrate, monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol can be used. , As the sweetener, natural sweeteners such as taumatine and stevia extract, or synthetic sweeteners such as saccharin and aspartame can be used.
본 발명에 따른 건강기능식품에 함유된 상기 추출물의 유효 용량은 피부 주름개선 목적에 따라 적절하게 조절될 수 있다. 상기 조성물은 천연물 및 식품을 원료로 하여 일반 약품의 장기 복용 시 발생할 수 있는 부작용 등이 없는 장점이 있고, 휴대성이 뛰어나, 피부 주름개선을 위한 보조제로 섭취될 수 있다.The effective dose of the extract contained in the health functional food according to the present invention may be appropriately adjusted according to the purpose of skin wrinkle improvement. The composition has the advantage of not having side effects that may occur during long-term use of general drugs by using natural products and food as raw materials, and has excellent portability, and can be taken as an adjuvant for skin wrinkle improvement.
또한, 본 발명은 흰민들레 추출물, 달맞이꽃 추출물 및 산양삼수를 포함하는 엘라스타제 활성 억제용 시약 조성물을 제공할 수 있다.In addition, the present invention may provide a reagent composition for inhibiting elastase activity comprising a white dandelion extract, an evening primrose extract and wild ginseng water.
이에 상응하는 특징들은 상술된 부분에서 대신할 수 있다.Corresponding features may be substituted for the above-mentioned parts.
이하, 본 발명의 이해를 돕기 위하여 실시예를 들어 상세하게 설명하기로 한다. 다만 하기의 실시예는 본 발명의 내용을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples will be described in detail to help the understanding of the present invention. However, the following examples are merely illustrative of the content of the present invention, and the scope of the present invention is not limited to the following examples. The embodiments of the present invention are provided to more completely explain the present invention to those of ordinary skill in the art.
<실시예 1> 강원도 특산 작물을 이용한 기능성 화장료 복합원료 제조<Example 1> Preparation of functional cosmetic composite raw materials using Gangwon-do specialty crops
1. 원료1. Raw material
포영공(양구 흰민들레, 건초 600g), 달맞이꽃(건초 600g), 평창 산양삼수(증기추출법으로 추출액 3kg)을 준비하였다 (도 1). Poyeonggong (Yanggu white dandelion, hay 600g), evening primrose (600g hay), and Pyeongchang wild ginseng water (3 kg of extract by steam extraction) were prepared (FIG. 1).
2. 전처리2. Pretreatment
준비된 생과 및 건조 원료는 사용의 용이와 원료수급 추출방법의 일원화를 위하여 하기와 같은 순서로 전처리하여 추출원료로 사용하였다.The prepared raw fruits and dried raw materials were pre-treated in the following order and used as extraction raw materials for ease of use and unification of raw material supply and demand extraction methods.
1) 저온 건조 : 30℃의 저온 건조 온도로 건조기 내부의 습기를 제거하며 12~15시간 1차 건조를 실시하였다. 1차 건조 완료 후 시료의 보수적 수분율은 20% 이내 이다.1) Low-temperature drying: Primary drying was performed for 12-15 hours while removing moisture inside the dryer at a low-temperature drying temperature of 30°C. After completion of the primary drying, the conservative moisture content of the sample is within 20%.
2) 동결 건조 : 시료의 부패방지 및 보관성의 용이성과, 최대 수분율 감소를 위하여, -20℃로 동결 건조를 실시하여 최소 수분함량 7%, 실험 시료 수분 함량을 13% 이하로 유지하여 시료를 전처리 하였다.2) Freeze-drying: In order to prevent spoilage of the sample, ease of storage, and reduce the maximum moisture content, freeze-drying at -20°C to keep the minimum moisture content of 7% and the moisture content of the test sample at 13% or less to pre-treat the sample. did
3) 분쇄 : 분쇄기(IKA A11 basic)를 사용하여 40mesh 이하로 분쇄한 분말을 -20℃로 보관하여 실험에 사용하였다.3) Grinding: The powder pulverized to 40 mesh or less using a grinder (IKA A11 basic) was stored at -20°C and used in the experiment.
3. 추출공정3. Extraction process
1) 포영공 (흰민들레)1) Poyeonggong (white dandelion)
흰민들레의 건조 꽃, 잎, 뿌리 부분을 혼합 분쇄한 시료를 이용하여 추출실험을 진행하였다. 열수 추출은 상기 분쇄시료 100g에 10배의 증류수를 가한 후, 100℃에서 2시간 동안 3회 반복 추출하여 진행하였고, 유기 용매 추출은 상기 분쇄시료 100g에 10배의 70% 에탄올을 이용하여 80℃에서 3시간 동안 3회 반복 추출하여 진행하였다.Extraction experiments were conducted using samples obtained by mixing and pulverizing dried flowers, leaves, and roots of white dandelion. Hot water extraction was performed by adding 10 times distilled water to 100 g of the pulverized sample, followed by extraction three times for 2 hours at 100 ° C., and organic solvent extraction was performed using 10
하기 표 1은 상기 두 추출방법에 따른 흰민들레 추출물의 수율을 비교한 것이다.Table 1 below compares the yield of white dandelion extract according to the two extraction methods.
(%, dry basis)Average Yields
(%, dry basis)
이를 통해, 유기 용매추출법에서 흰만들레의 추출 수율이 높은 것으로 나타나, 흰민들레의 최적 추출법은 유기 용매추출법으로 정하여, 추출공정을 표준화하였다 (도 2).Through this, it was found that the extraction yield of white dandelion was high in the organic solvent extraction method, and the optimal extraction method of white dandelion was set as the organic solvent extraction method, and the extraction process was standardized (FIG. 2).
2) 달맞이꽃2) Evening primrose
달맞이꽃, 씨, 수술의 추출물은 지용성 추출물의 연구결과를 통하여 유기용매 추출법이 적합할 것으로 예상된다. 열탕 추출은 달맞이꽃 건초 분쇄시료 100g에 14배의 증류수를 가한 후 100℃에서 2시간 동안 끓인 후 실온에서 10시간 식힘을 2회 반복하여 환류 추출하고 이를 3회 진행하였다. 유기 용매 추출은 상기 분쇄시료 100g에 10배의 70% 에탄올을 가한 후, 25±2℃의 실온에서 교반기를 이용하여 150rpm으로 12시간 상온교반추출(stirrer extraction, SE)하였고 이를 3회 반복 추출하였다.For extracts of evening primrose, seeds and stamens, the organic solvent extraction method is expected to be suitable through the study results of fat-soluble extracts. For hot water extraction, 14 times distilled water was added to 100 g of pulverized evening primrose hay sample, boiled at 100° C. for 2 hours, cooled at room temperature for 10 hours, and then extracted under reflux twice. For organic solvent extraction, 10
하기 표 2는 상기 두 추출방법에 따른 달맞이꽃 추출물의 수율을 비교한 것이다.Table 2 below compares the yield of the evening primrose extract according to the two extraction methods.
(%, dry basis)Average Yields
(%, dry basis)
이를 참조하면, 열탕 추출의 추출수율이 높지만, 추출과정의 시간 대비 유기용매 상온교반추출(SE)법의 추출수율이 효과적이어서 유기 용매추출법으로 표준화하였다 (도 2).Referring to this, although the extraction yield of hot water extraction is high, the extraction yield of the organic solvent room temperature stirring extraction (SE) method is effective compared to the time of the extraction process, so it was standardized to the organic solvent extraction method (FIG. 2).
3) 산양삼수3) Goat ginseng water
원료 특성상 고가인 관계로 산양삼 재배업체의 직접생산 산양삼수(WGDE)를 제공 받아 농축단계를 거처 시료로 사용하였다. Due to the high price of raw materials, we received WGDE directly produced by a wild ginseng grower and went through a concentration step to use it as a sample.
제조사 고시 추출방법은 하기와 같다.The extraction method notified by the manufacturer is as follows.
산양삼수(WGDE)의 추출은 증류추출기를 이용하였다. 100g의 건조된 산양삼에 1L의 증류수를 넣고 3시간 환류추출로 전탕하였다. 전탕 후 환류추출기에 냉각수 공급을 중단한 후 증발되는 수증기를 포집액화하여 사용하였다 (도 3).For extraction of wild ginseng water (WGDE), a distillation extractor was used. 1 L of distilled water was added to 100 g of dried wild ginseng, and hot water was performed by reflux extraction for 3 hours. After boiling, the water vapor evaporated after stopping the supply of cooling water to the reflux extractor was collected and used as a liquid (FIG. 3).
4. 원심분리 및 기능성 성분 농축공정4. Centrifugation and functional ingredient concentration process
상기의 추출공정으로 추출한 추출물의 잔여물 및 유기용매를 제거하고 성분 농도를 높이기 위한 방법으로 농축공정을 반복 실행하였다.The concentration process was repeated as a method to remove the residues and organic solvents of the extract extracted by the above extraction process and to increase the component concentration.
1) 1차 정제 : 여과1) Primary purification: filtration
각각의 추출물은 Whatman No. 1 여과지로 불순물 등을 여과하는 1차 여과 과정을 거친 후, 분말 활성탄을 활용하여 여과층을 형성하고 추출물을 통과시켜 추출물 내의 오염물질을 흡착하고 용매 및 식물 내의 엽록소 성분을 분리시키는 2차 여과 과정을 수행하였다.Each extract was prepared according to Whatman No. 1 After the primary filtration process of filtering impurities, etc. with a filter paper, a filtration layer is formed using powdered activated carbon, and the extract is passed through the secondary filtration process to adsorb contaminants in the extract and separate solvents and chlorophyll components in plants was performed.
2) 2차 정제 : 원심분리2) Secondary purification: centrifugation
원심분리 장치 라보젠 416G(labogene 416G)를 사용하여 1차 정제된 추출물을 2,000-3,000rpm으로 7-15분 동안 원심분리한 후, 상등액만을 여과하여 조 추출물(crude extract)을 제조 단계별로 분획하여 식물 유효성분을 추출 정제하였다.The first purified extract was centrifuged at 2,000-3,000 rpm for 7-15 minutes using a centrifugal device Labogene 416G, and only the supernatant was filtered to fractionate the crude extract step by step. Plant active ingredients were extracted and purified.
3) 농축 : 환류 농축 (회전감압농축, 진공증발법)3) Concentration: reflux concentration (rotary reduced pressure concentration, vacuum evaporation method)
상기 2차 정제 단계를 완료한 추출물의 성분에 농축 단계를 더하여 고순도 성분을 획득하는 단계로, 감압농축기 EYELA N-1300으로 추출물의 에탄올과 같은 용매제를 증발시켜 건조·폐액처리 하여 추출액의 순수 추출물을 응집하고 층분리를 이용하여 분획하였다. 수조(Water bath)의 온도는 35℃~42℃로 유지하고, 비등점에 대한 진공은 175mbar, 회전수는 140~200rpm (용매: 에탄올-140rpm, 증류수-200rpm)의 조건에서 수행하였다. This is a step to obtain high-purity components by adding a concentration step to the components of the extract that has completed the second purification step. The pure extract of the extract is dried by evaporating a solvent such as ethanol of the extract with a reduced pressure concentrator EYELA N-1300 and drying and waste treatment. was aggregated and fractionated using layer separation. The temperature of the water bath was maintained at 35 ° C. to 42 ° C., the vacuum for the boiling point was 175 mbar, and the rotation speed was 140 to 200 rpm (solvent: ethanol-140 rpm, distilled water-200 rpm).
5. 혼합 믹싱 및 제형분리 공정5. Mixing Mixing and Formulation Separation Process
상기의 농축과정을 거친 고순도 추출액을 기능성별 혼합 믹싱과정과 동결건조 과정을 통해 화장료 성분을 개발하였다. 농축한 추출액을 동결건조 후, -40℃에서 보관하였다. 혼합 파우더 Complex는 각 추출물을 동결건조하여 분말화한 원료를 혼합하는 방법과 액상상태의 혼합 Complex 원료를 동결건조하여 분말화하는 방법으로 나눌 수 있지만, 후자의 경우 혼합 원료상의 부패 및 보관과 용해시 잔존물의 비율이 높아져 전자의 방법으로 파우더 형태의 원료를 제조 방식을 택하였다. 최종 표준화 공정은 도 4와 같다. Cosmetic ingredients were developed through mixing, mixing, and freeze-drying processes by functionalities of the high-purity extracts that went through the above-mentioned concentration process. After freeze-drying the concentrated extract, it was stored at -40°C. Mixed powder complex can be divided into a method of mixing powdered raw materials by freeze-drying each extract and a method of freeze-drying and powdering a liquid mixed complex raw material. The ratio of residues was high, so the former method was used to prepare raw materials in powder form. The final standardization process is shown in FIG. 4 .
Waters HPLC system를 사용하여 포영공(흰민들레), 달맞이꽃, 산양삼 추출물의 기능성 주요 성분을 다음과 같이 확인하였다. Using the Waters HPLC system, the functional main components of the extracts of purpurea (white dandelion), evening primrose and wild ginseng were confirmed as follows.
하기 표 3은 C18-Column을 적용하여 HPLC 분석을 이용한 각 추출물의 주요 기능성 성분을 나타낸 것이다.Table 3 below shows the main functional components of each extract using HPLC analysis by applying C18-Column.
<제조예 1> 기능성 화장료 제조 - GSP_A(Gangwon Special Plant_Anti-aging)<Preparation Example 1> Manufacturing of functional cosmetics - GSP_A (Gangwon Special Plant_Anti-aging)
하기 표 4의 성분 및 함량으로 기능성 화장료 GSP_W를 제조하여 이의 기능성을 확인하였다. Functional cosmetic GSP_W was prepared with the ingredients and contents of Table 4 below, and its functionality was confirmed.
<실험예 1> 세포 독성 실험<Experimental Example 1> Cytotoxicity test
화장품 소재로서의 안전성을 평가하기 위하여 세포생존율을 MTT assay로 측정하였다. B16 F10 마우스 흑색종 세포(mouse melanoma cell)(한국세포주은행)를 1×104 cell/ml씩 분주하여 24시간 배양 후 10~1,000μg/ml의 농도로 희석한 추출물의 시료가 첨가된 새 배지로 교체하고 다시 24시간 동안 배양하였다. 여기에 MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-trazolium bromide, Sigma)를 각 well당 20μl 첨가한 후, 37℃, 5% CO2 incubator(Sanyo, Japan)에서 배양 2시간 후 형성된 formazan을 200μl DMSO에 녹이고, 595nm에서 ELISA reader (PowerWaveXS2, BioTek, USA)로 흡광도를 측정하였다. In order to evaluate the safety as a cosmetic material, the cell viability was measured by MTT assay. B16 F10 mouse melanoma cells (Korea Cell Line Bank) were aliquoted at 1×10 4 cells/ml and cultured for 24 hours, followed by a fresh medium containing a sample of the extract diluted to a concentration of 10 to 1,000 μg/ml. was replaced with and incubated for 24 hours again. After adding 20 μl of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-trazolium bromide, Sigma) to each well, 37℃, 5% CO 2 incubator (Sanyo, Japan) ), the formazan formed after 2 hours of incubation was dissolved in 200 μl DMSO, and absorbance was measured at 595 nm with an ELISA reader (PowerWaveXS2, BioTek, USA).
세포 생존율(cell viability)은 하기 식 1로 계산되었다.Cell viability was calculated by
<식 1> Cell viability(%)=[(Exp.-Blank)/Control]×100<
제조예 1에 따라 제조된 화장료 GSP_A와 비타민 C를 대조군으로 하여, 추출물을 10~1,000μg/ml의 농도로 희석하여 세포 독성을 시험한 결과, 도 5에 나타난 바와 같이, GSP_A는 1,000μg/ml에서 80% 이상의 세포생존율을 보여 높은 농도에서도 안전하다는 것을 보여주었다.Using the cosmetic GSP_A and vitamin C prepared according to Preparation Example 1 as a control, the extract was diluted to a concentration of 10-1,000 μg/ml and tested for cytotoxicity, as shown in FIG. 5 , GSP_A was 1,000 μg/ml showed that it was safe even at high concentrations by showing more than 80% cell viability in
실험결과는 평균±표준편차(Mean±S.D.)로 표기하였으며, 통계처리는 Student‘sunpairedt-test와 ANOVA를 이용하여 분석하였고, p<0.05일 때 유의성이 있는 차이가 있다고 판정하였다. 이하 실험에서도 동일하게 적용되었다.Experimental results were expressed as mean ± standard deviation (Mean ± S.D.), and statistical processing was analyzed using Student'sunpairedt-test and ANOVA, and it was determined that there was a significant difference when p <0.05. The same was applied to the following experiments.
<실험예 2> 최적 혼합비 확인<Experimental Example 2> Confirmation of optimal mixing ratio
각각의 최적 혼합비를 확인하기 위해 혼합 추출물의 보습효과 실험을 진행하였다. 보습룰은 화장료의 기본적인 특성으로 피부장벽 개선에 가장 기초적 측정치로, 미백 및 주름개선의 유효성과 적합 혼합 비율을 확인할 수 있다.In order to confirm each optimal mixing ratio, an experiment on the moisturizing effect of the mixed extract was conducted. The moisturizing rule is the most basic measure for improving the skin barrier as a basic characteristic of cosmetics.
하기 표 5는 각 추출물 혼합비에 따른 시간별 보습 효과를 나타낸 것으로, 이를 참조하면, 액상 Complex 화장료의 중량비로 총 중량 100g 당 주름개선 기능성 추출물(GSP_A)의 혼합비율이 1:2:7 일 때, 보습 효과가 가장 우수한 것으로 확인되었다. 수상 층인 산양삼수에 상기 원료의 액상화 (100배의 증류수에 용해한 후 30분뒤 상등액을 취하여 사용) 원료를 75℃, 11,000rpm으로 15분간 가열 교반하여 사용하였다.Table 5 below shows the moisturizing effect over time according to each extract mixing ratio. Referring to this, when the mixing ratio of the wrinkle-improving functional extract (GSP_A) per 100 g of the total weight as a weight ratio of the liquid complex cosmetic is 1:2:7, moisturizing It was confirmed that the effect was the best. The raw material was liquefied (dissolved in 100 times distilled water, and the supernatant was used after 30 minutes) in the aqueous phase, goat ginseng water, and the raw material was heated and stirred at 75° C. and 11,000 rpm for 15 minutes.
<실험예 3> 주름개선 기능성 확인<Experimental Example 3> Wrinkle improvement functional confirmation
흰민들레, 달맞이꽃, 및 산양삼 추출물을 혼합(1:2:7의 비율)하여 주름개선 기능성을 확인하였다.White dandelion, evening primrose, and wild ginseng extracts were mixed (ratio of 1:2:7) to confirm the wrinkle improvement function.
1. 항산화 활성 확인1. Confirmation of antioxidant activity
DPPH 방법에 의한 항산화 활성은 Blois 방법에 따라 측정하였다. GSP_A추출물 0.2mL에 0.4mM DPPH 3.8mL을 가하고 10초간 혼합한 후, 실온에서 30분간 반응시키고 517nm 파장에서 흡광도를 측정하였다. 음성대조군은 시료 대신 에탄올을 동량 첨가하여 실험하였고, 양성대조군으로는 합성 항산화제인 BHA(butylated hydroxyanisole)를 이용하여 동일한 방법으로 실시하였다.Antioxidant activity by the DPPH method was measured according to the Blois method. After adding 3.8 mL of 0.4 mM DPPH to 0.2 mL of the GSP_A extract, mixing for 10 seconds, reacting at room temperature for 30 minutes, and measuring absorbance at 517 nm wavelength. The negative control group was tested by adding the same amount of ethanol instead of the sample, and as a positive control group, synthetic antioxidant BHA (butylated hydroxyanisole) was used in the same way.
그 결과, 도 6에 나타난 바와 같이, GSP_A 추출물의 DPPH 라디칼 소거능은 농도 의존적으로 증가하였다. 500μg/mL의 농도에서 BHA와 유사한 효과를 나타내었으며, 나머지 농도(10, 50, 100μg/mL)에서는 BHA 보다 낮은 효과를 나타내었다.As a result, as shown in FIG. 6 , the DPPH radical scavenging ability of the GSP_A extract was increased in a concentration-dependent manner. At a concentration of 500 μg/mL, an effect similar to that of BHA was exhibited, and at the remaining concentrations (10, 50, 100 μg/mL), the effect was lower than that of BHA.
혼합 원료의 각각 성분들은 항산화 화합물을 보유하고 있으며, 특히 플라보노이드 화합물을 함유하고 있는 것을 HPLC 분석을 통해 앞서 확인한 바 있다. 이를 통해, 본 발명에 따른 GSP_A 추출물은 항산화 활성이 높은 것으로 판단할 수 있다.Each component of the mixed raw material has antioxidant compounds, and in particular, it has been previously confirmed through HPLC analysis that they contain flavonoid compounds. Through this, it can be determined that the GSP_A extract according to the present invention has high antioxidant activity.
2. 엘라스타제(elastase) 활성 억제 확인2. Confirmation of inhibition of elastase activity
기질 1.0 mM N-succinyl-(Ala)3-p-nitroanilide (Sigma) 200μl에 GSP_A Complex 100-1,000μg/ml로 희석시킨 시료용액 20μl와 2.5U 엘라스타제(porcinepancreas solution) 10μl을 첨가하여 25℃에서 10분 동안 반응한 후 ELISA reader로 410nm에서 흡광도를 측정하였다. 대조군으로는 주름개선 기능성 화장품 소재로서 널리 사용되는 아데노신(adenosine)을 이용하였다. To 200 μl of substrate 1.0 mM N-succinyl-(Ala)3-p-nitroanilide (Sigma), 20 μl of a sample solution diluted with 100-1,000 μg/ml of GSP_A Complex and 10 μl of 2.5U elastase (porcinepancreas solution) were added at 25°C. After reacting for 10 minutes, absorbance was measured at 410 nm with an ELISA reader. As a control group, adenosine, which is widely used as a functional cosmetic material for wrinkle improvement, was used.
그 결과, 도 7에 나타난 바와 같이, GSP_A Complex 원료의 500μg/ml의 농도에서 68%의 억제율로, 대조군인 adenosine과 유사한 주름개선 효과를 나타내었다. 문헌을 참조하면, elastase 억제 효과를 보이는 식물은 500μg/ml의 농도에서 산수유나무(Cornus controversa Hemsl.)가 80%, 센달나무(Machilus japonica Siebold)가 77%, 삼나무(Cryptomeria japonica)가 73% 그리고 들장미(Rosa multiflora)가 73%의 억제 효과를 보여주었다. 위 식물들과 비교하여 GSP_A Complex 원료의 elastase 억제율은 유사하거나 비교적 우수한 효과를 보여주는 것으로 판단할 수 있다.As a result, as shown in FIG. 7 , at a concentration of 500 μg/ml of the GSP_A Complex raw material, an inhibitory rate of 68%, a wrinkle improvement effect similar to that of adenosine, a control group, was exhibited. Referring to the literature, the plants showing the elastase inhibitory effect at a concentration of 500 μg/ml were cornus controversa Hemsl. 80%, Machilus japonica Siebold 77%, cedar ( Cryptomeria japonica ) 73% and Wild rose ( Rosa multiflora ) showed an inhibitory effect of 73%. Compared to the above plants, the elastase inhibition rate of the GSP_A Complex raw material can be judged to show a similar or relatively superior effect.
<실험예 4> 원료 시험<Experimental Example 4> Raw material test
성상, 향취, 안정도(48 hrs), pH, 납(Pb) 함유량, 비소(As) 함유량, 미생물(Microbes) 항목에 대해 원료 시험을 시행하였다. 시험 항목 중 Pb(납) 함유량 시험의 경우 점토질 또는 토양관련 시료에 적용되는 시험 방법으로, 본 실험예에서는 기능성별 액상 원료에 대하여 점도 실험으로 대체하여 7종의 실험을 실행하였으며, 파우더형 원료의 경우 점도를 가질 수 없기 때문에 발주자와 협의하여 6종의 시험을 시행하였다.Raw material tests were performed on properties, odor, stability (48 hrs), pH, lead (Pb) content, arsenic (As) content, and microorganisms. Among the test items, the Pb (lead) content test is a test method applied to clay or soil-related samples. In this experimental example, 7 kinds of experiments were performed by replacing the viscosity test for liquid raw materials for each function. In this case, since it cannot have viscosity, six types of tests were conducted in consultation with the client.
하기 표 6은 GSP_A 액상 원료 100g을 채취하여 진행한 원료 시험 결과이다,Table 6 below is the raw material test result obtained by collecting 100 g of GSP_A liquid raw material,
하기 표 7는 GSP_A 파우더 원료 100g을 채취하여 진행한 원료 시험 결과이다.Table 7 below shows the raw material test results obtained by collecting 100 g of GSP_A powder raw material.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 즉, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다.As described above in detail a specific part of the content of the present invention, for those of ordinary skill in the art, it is clear that this specific description is only a preferred embodiment, and the scope of the present invention is not limited thereby. do. That is, the substantial scope of the present invention is defined by the appended claims and their equivalents.
Claims (14)
상기 조성물은,
아데노신, 하이알루로네이트, 및 글리세린으로 이루어진 군에서 선택된 하나 이상의 성분을 추가로 포함하는 것을 특징으로 하는 주름개선용 화장료 조성물.The method of claim 1,
The composition is
A cosmetic composition for improving wrinkles, characterized in that it further comprises one or more components selected from the group consisting of adenosine, hyaluronate, and glycerin.
상기 조성물은,
용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 에센스, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 제형을 갖는 것을 특징으로 하는 주름개선용 화장료 조성물.The method of claim 1,
The composition is
having a formulation selected from the group consisting of solutions, suspensions, emulsions, pastes, gels, creams, essences, lotions, powders, soaps, surfactant-containing cleansings, oils, powder foundations, emulsion foundations, wax foundations and sprays A cosmetic composition for wrinkle improvement, characterized in that.
상기 조성물은,
연화제, 항산화제, 현탁화제, 발포제, 계면활성제, 정제수, 이온형 또는 비이온형 유화제, 충전제, 보존제, 비타민, 차단제, 습윤화제, 염료, 안료, 친수성 또는 친유성 활성제 중에서 선택된 어느 하나 이상의 보조제를 추가로 포함하는 것을 특징으로 하는 이너뷰티(inner beauty)용 조성물.9. The method of claim 8,
The composition is
Any one or more adjuvants selected from emollients, antioxidants, suspending agents, foaming agents, surfactants, purified water, ionic or non-ionic emulsifiers, fillers, preservatives, vitamins, blocking agents, wetting agents, dyes, pigments, hydrophilic or lipophilic active agents Composition for inner beauty (inner beauty), characterized in that it further comprises.
상기 조성물은,
구강 점막용 필름, 정제, 시럽, 캡슐, 환제, 과립, 분말, 에어로졸 중에서 선택된 어느 하나 이상의 제형으로 이루어지는 것을 특징으로 하는 이너뷰티(inner beauty)용 조성물.9. The method of claim 8,
The composition is
A composition for inner beauty, characterized in that it consists of any one or more formulations selected from oral mucosa films, tablets, syrups, capsules, pills, granules, powders, and aerosols.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200186277A KR102334192B1 (en) | 2020-12-29 | 2020-12-29 | Functional cosmetic composition comprising korean dandelion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200186277A KR102334192B1 (en) | 2020-12-29 | 2020-12-29 | Functional cosmetic composition comprising korean dandelion |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102334192B1 true KR102334192B1 (en) | 2021-12-03 |
Family
ID=78866657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200186277A KR102334192B1 (en) | 2020-12-29 | 2020-12-29 | Functional cosmetic composition comprising korean dandelion |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102334192B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100878080B1 (en) | 2007-03-02 | 2009-01-13 | 최완정 | A composite of nutrition pack for skin beauty and making method thereof |
KR101072027B1 (en) * | 2008-11-28 | 2011-10-10 | (주)아모레퍼시픽 | Anti-aging cosmetic composition improving skin elasticity |
KR20160054668A (en) * | 2014-11-06 | 2016-05-17 | 주식회사 엘지생활건강 | Composition for promoting synthesis of hyaluronic acid comprising Taraxacum herbs extracts and the use thereof |
-
2020
- 2020-12-29 KR KR1020200186277A patent/KR102334192B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100878080B1 (en) | 2007-03-02 | 2009-01-13 | 최완정 | A composite of nutrition pack for skin beauty and making method thereof |
KR101072027B1 (en) * | 2008-11-28 | 2011-10-10 | (주)아모레퍼시픽 | Anti-aging cosmetic composition improving skin elasticity |
KR20160054668A (en) * | 2014-11-06 | 2016-05-17 | 주식회사 엘지생활건강 | Composition for promoting synthesis of hyaluronic acid comprising Taraxacum herbs extracts and the use thereof |
Non-Patent Citations (2)
Title |
---|
Dae-yeon Lee 외 4명, "Comparison of Index Compounds Content and Antioxidative Activity of Wild Ginseng Pharmacopuncture by Extraction Methods", J Int Korean Med., Vol. 39, No. 3, pp. 313-322, 2018.06.30* * |
Myeong-Wook Kim 외 4명, "Beauty food activities of wild-cultivated Ginseng (Panax ginseng C.A. Meyer) ground part", J Appl Biol Chem., Vol. 61, No. 1, pp. 33-38, 2018.03.31.(온라인 공개일)* * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102113193B1 (en) | Composition for improving skin conditions comprising artemisiae annuae herba, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
CN114929195A (en) | Composition containing plant extract | |
JP5616045B2 (en) | Ceramide production promoter and moisturizer | |
JP2004323362A (en) | Composition comprising extract from plant of genus bidens | |
WO2011043212A1 (en) | Ceramide production enhancer and moisturizing agent | |
KR102228257B1 (en) | Composition for anti-inflammation or anti-acne comprising extract of Immature Citrus Fruit, Curcuma longa and citrus blossom honey | |
KR101033921B1 (en) | Composition for reducing irritation and inflammation in skin | |
KR101065356B1 (en) | Cosmetic application of defatted Camellia japonica Seed debris and seed coats and its extract | |
JP6059510B2 (en) | Ceramide production promoter | |
KR102334192B1 (en) | Functional cosmetic composition comprising korean dandelion | |
KR101367703B1 (en) | Composition of cosmetic and treating skin disease | |
KR101501538B1 (en) | Composition for External Application to the Skin Using an Extract of Seeds of Opuntia ficus-indica var. saboten | |
KR102343245B1 (en) | Composition for preventing, ameliorating or treating atopic dermatitis comprising Chrysanthemum indicum L. oil extract as effective component | |
KR102315700B1 (en) | Composition for treating or preventing acne comprising elaeagnus umbellata leaves extract | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR102176883B1 (en) | Composition for skin regeneration, anti-wrinkle, or wound healing containing Prunus persica resin | |
KR20140137796A (en) | Food Composition for Reducing Joint Pain Comprising Achyranthes japonica Nakai, Sorbus commixta and Soybean Extract | |
KR20180050798A (en) | Cosmetic compositions containing Zingiberaceae extracts for skin homeostasis and nontoxicity and manufacturing method thereof | |
KR102012366B1 (en) | Composition for whitening comprising Withania somnifera callus extract | |
KR20220163542A (en) | Composition for anti-oxidation, anti-inflammation, and anti-pollution containing an extraction of Backhousia citriodora and Sparassis crispa | |
KR102334191B1 (en) | Functional cosmetic composition comprising potato | |
JP5325727B2 (en) | Sendangusa plant extract-containing composition | |
JP5689247B2 (en) | Ceramide production promoter and moisturizer | |
KR101083029B1 (en) | A cosmetic composition containing rice germ and Coptis chinensis extracts for absorbing Ultraviolet | |
JP2019182863A (en) | Skin firmness or moisture improving composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
N231 | Notification of change of applicant | ||
GRNT | Written decision to grant |